Aims Short-term disul®ram administration has been shown to selectively inhibit CYP2E1 activity but the effects of chronic disul®ram administration on the activities of drug metabolizing enzymes is unclear. The purpose of this study was to evaluate the effects of disul®ram given for 11 days on selected drug metabolizing enzyme activities. Methods Seven healthy volunteers were given disul®ram 250 mg daily for 11 days. Activities of the drug metabolizing enzymes CYP1A2, CYP2C19, CYP2D6, CYP2E1 and N-acetyltransferase were determined using the probe drugs caffeine, mephenytoin, debrisoquine, chlorzoxazone, and dapsone, respectively. Chlorzoxazone was administered before disul®ram administration and after the second and eleventh doses of disul®ram, while the other probe drugs were given before disul®ram administration and after the eleventh disul®ram dose. Results Disul®ram administration markedly inhibited chlorzoxazone 6-hydroxylation by more than 95%, but did not affect metabolism of debrisoquine or mephenytoin. Caffeine N3-demethylation was decreased by 34% (P<0.05). Monoacetyldapsone concentrations were markedly elevated by disul®ram administration resulting in a nearly 16-fold increase in the dapsone acetylation index, calculated as the plasma concentration ratio of monoacetyldapsone to dapsone. CYP-mediated dapsone N-hydroxylation was not signi®cantly altered. Conclusions These data suggest that disul®ram-mediated inhibition is predominantly selective for CYP2E1. The magnitude of CYP2E1 inhibition was similar after both acute and chronic disul®ram administration. The effects on caffeine N3-demethylation (CYP1A2) and dapsone metabolism suggest that chronic disul®ram administration may affect multiple drug metabolizing enzymes, which could potentially complicate the use of chronically administered disul®ram as a diagnostic inhibitor of CYP2E1.